Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis.
Frontiers in immunology（2022）
摘要
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42021288907.
更多查看译文
关键词
combination therapy,janus kinase inhibitors,methotrexate,monotherapy,rheumatoid arthritis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要